SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bob Trocchi who wrote (7029)1/30/2000 11:53:00 AM
From: Hank  Read Replies (1) of 7041
 
Actually, I think that article is the very reason why you should short it now. It points out the fact that there are many other worthy competitors for Viagra just waiting for approval, of which Vasoscam is not one. Vasoscam will never get approval. Even if it did, it wouldn't stand a chance against the many superior competing products. Plus, by the time ZONA works through all of the FDA's objections to Vasoscam, the other drugs will be on the shelf. Vasoscam would, at best, be the last one to the party.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News